ArticleDrugs in R&D2025

Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.

Mark T Reding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.